Pluri(IL:PLUR)
ILA 302.60-11.80 (-3.75%)
IL:PLUR
Pluri similar stocks
ILA 302.60
At close:-11.80 (-3.75%)
Compare Pluri (PLUR) vs. Competitors
1 Followers
Comparison Results
| Name | Price | Market Cap | P/E Ratio | Yearly Gain | Analyst Consensus | Analyst Price Target | Compare | Top Analysts' Price Target | Smart Score | Follow |
|---|---|---|---|---|---|---|---|---|---|---|
| IL:PLURPluri | ILA 302.60 | ILA 46.18M | -0.39 | -74.97% | ― | Unlock the IL:PLUR analyst price target with TipRanks Premium | IL:PLUR | Unlock the IL:PLUR top-analyst price target with TipRanks Premium | ||
| IGCIGC Pharma | $0.19 | $22.71M | -2.37 | -42.09% | Moderate Buy | Unlock the IGC analyst price target with TipRanks Premium | IL:PLUR vs IGC | Unlock the IGC top-analyst price target with TipRanks Premium | ||
| PYPDPolyPid | $6.56 | $138.58M | -4.86 | 80.22% | Strong Buy | Unlock the PYPD analyst price target with TipRanks Premium | IL:PLUR vs PYPD | Unlock the PYPD top-analyst price target with TipRanks Premium | ||
| ANTXAN2 Therapeutics, Inc. | $4.95 | $160.50M | -5.32 | 341.96% | ― | Unlock the ANTX analyst price target with TipRanks Premium | IL:PLUR vs ANTX | Unlock the ANTX top-analyst price target with TipRanks Premium |
Performance Comparison
| Ticker | Company Name | Price | Change | % Change | |
|---|---|---|---|---|---|
| IL:PLUR | Pluri | 302.60 | -906.40 | -74.97% | |
| IGC | IGC Pharma | 0.19 | -0.13 | -40.49% | |
| PYPD | PolyPid | 6.56 | 2.96 | 82.22% | |
| ANTX | AN2 Therapeutics, Inc. | 4.95 | 3.87 | 358.33% |
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts

